Sign in
4

Changes in Ownership

Encompass Health Corp Filed Acc 0001127602-25-015049

President & CEO sold 118,384 shares at an average $121.53 ($14,387,152)

  • President & CEO acquired 118,384 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Tarr Mark J President & CEO 2025-05-20 Option exercise +56,306 $35.06 $1,974,088 583,376 D: show line 1 in the form
Tarr Mark J President & CEO 2025-05-20 Option exercise +62,078 $44.67 $2,773,024 645,454 D: show line 2 in the form
Tarr Mark J President & CEO 2025-05-20 Sale −94 $120.94 $11,368 645,360 D: show line 3 in the form
Tarr Mark J President & CEO 2025-05-20 Sale −118,290 $121.53 $14,375,784 527,070 D: show line 4 in the form
Open-market sales · 118,384 sh · avg $121.53 · $14,387,152

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Tarr Mark J President & CEO 2025-05-20 Option exercise · Non-qualified Stock Option (Right to Buy) −56,306 0 D: show line 5 in the form
Tarr Mark J President & CEO 2025-05-20 Option exercise · Non-qualified Stock Option (Right to Buy) −62,078 0 D: show line 6 in the form
Loading xslF345X05/form4.xml…